A study of sixty pregnancies in patients with the antiphospholipid syndrome

Clinical and Experimental Rheumatology

Volumn 14, Issue 2, 1996, Pages 131-136

  Lima, F ^a   Khamashta, M A ^a   Buchanan, N M M ^a   Kerslake, S ^a   Hunt, B J ^a   Hughes, G R V ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

antiphospholipid antibodies; aspirin; fetal death; low molecular weight heparin; systemic lupus erythematosus; thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; AZATHIOPRINE; HEPARIN; HYDROXYCHLOROQUINE; LOW MOLECULAR WEIGHT HEPARIN; PREDNISOLONE;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CLINICAL ARTICLE; EMBRYO; FEMALE; FETUS; HUMAN; ORAL DRUG ADMINISTRATION; PREGNANCY DISORDER; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOSIS;

ABORTION, HABITUAL; ADULT; ANTIPHOSPHOLIPID SYNDROME; ASPIRIN; FEMALE; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MEDICAL RECORDS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREGNANCY OUTCOME; THROMBOCYTOPENIA; THROMBOSIS;

EID: 0029884938     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. SANCHEZ-GUERRERO J, ALARCÒN-SEGOVIA D: Course of antiphospholipid antibodies in patients with primary antiphospholipid syndrome before, during and after pregnancy treated with low dose aspirin. Relationship of antibody levels to outcome in 7 patients. J Rheumatol 1992; 19: 1083-8.
2. MANY A, PAUZNER R, CARP H, LANGEVITZ P, MARTINOWITZ U: Treatment of patients with antiphospholipid syndrome during pregnancy. Am J Reprod Immunol 1992; 28: 216-8.
3. BRANCH DW, SILVER RM, BLACKWELL JL, READING JC, SCOTT JR: Outcome of treated pregnancies in women with antiphospholipid syndrome: An update of the Utah experience. Obstet Gynecol 1992; 80: 614-20.
4. REECE EA, GABRIELLI S, CULLEN MT, ZHENG X-Z, BOBBINS JC, HARRIS EN: Recurrent adverse pregnancy outcome and antiphospholipid antibodies. Am J Obstet Gynecol 1990; 163: 162-9.
5. SILVER RK, MACGREGOR SN, SHOLL JS, HOBART JM, NEERHOF MG, RAGIN A: Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients. Am J Obstet Gynecol 1993; 169: 1411-7.
6. LA ROSA L, MERONI PL, TINCANI A, BALESTRIERI G, FADEN D, LOJACONO A, MORASSI L, BROCCHI E, DEL PAPA N, GHARAVI AE, SAMMARITANO L, LOCKSHIN MD: β2 glycoprotein I and Placental Anticoagulant Protein I in placentae from patients with antiphospholipid syndrome. J Rheumatol 1944; 21: 1684-93.
7. BRANCH DW: Thoughts on the mechanism of pregnancy loss associated with the antiphospholipid syndrome. Lupus 1994; 3: 275-80.
8. STUART RA, QUINN MJ, MCHUGH NJ: Combined corticosteroid and aspirin treatment for the high risk lupus pregnancy. Br J Obstet Gynecol 1993; 100: 601-2.
9. BUCHANAN NMM, KHAMASHTA M, KERSLAKE S, HUNT BJ, HUGHES GRV: Practical management of pregnancy in systemic lupus erythematosus. Fetal Matern Med Rev 1993; 5: 223-30.
10. INBAR O, BLANK M, FADEN D, TINCANI A, LORBER M, SHOENFELD Y: Prevention of fetal loss in experimental antiphospholipid syndrome by low-molecular-weight heparin. Am J Obstet Gynecol 1993; 169: 423-6.
11. FISHMAN P, FALACH-VAKNINE E, ZIGELMAN R, BAKIMER R, SREDNI B, DJALDETTI M, SHOENFELD Y: Prevention of fetal loss in experimental antiphospholipid syndrome by in vivo administration of recombinant interleukm-3. J Clin Invest 1993; 21: 1834-7.
12. ASHERSON RA, KHAMASHTA MA, ORDI-ROS J, DERKSEN RHWM, MACHIN SJ, BARQUINERO J, OUT HH, HARRIS EN, VILARDELL-TARRES M, HUGHES GRV: The primary antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore) 1989; 68: 366-74.
13. THIAGARAJAN P, PENGO V, SHAPIRO SS: The use of the dilute Russel viper venom time for the diagnosis of lupus anticoagulant. Blood 1986; 68: 869-74.
14. HARRIS EN, GHARAVI AE, PATEL SP, HUGHES GRV: Evaluation of the anticardiolipin antibody test: report of an international workshop held 4 April 1986. Clin Exp Immunol 987; 68: 215-22.
15. KITRIDOU RC, MINTZ G: The mother in SLE. In WALLACE DJ and HAHN BH (Eds.): Dubois' Lupus Erythematosus, 4th ed. Philadelphia, Lea and Febiger, 1993: 487-507.
16. TAN EM, COHEN AS, FRIES JF et al.: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
17. COWCHOCK FS, REECE EA, BALABAN D, BRANCHE DW, PLOUFFE L: Repeated fetal losses associated with antiphospholipid antibodies: A collaborative randomized trial comparing prednisone with low-dose heparin treatment. Am J Obstet Gynecol 1992; 166: 1318-23.
18. ROSOVE MH, TABSH K, WASSERSTRUM N, HOWARD P, HAHN BH, KALUNIAN KC: Heparin therapy for pregnant women with lupus anticoagulant or anticardiolipin antibodies. Obstet Gynecol 1990; 75: 630-4.
19. BALASCH J, CARMONA F, LÓPEZ-SOTO A, FONT J, CREUS M, FABREGUES F, INGELMO M, VANRELL JA: Low-dose aspirin for prevention of pregnancy losses in women with primary antiphospholipid syndrome. Hum Reprod 1993; 8: 2234-9.
20. LOCKSHIN MD: Antiphospholipid antibody syndrome. Rheum Dis Clin North Am 1994; 20: 45-59.
21. PETRI M: Systemic lupus erythematosus and pregnancy. Rheum Dis Clin North Am 1994; 20: 87-118.
22. SHIFF E, MASHIACH S: The use of low dose aspirin in pregnancy. Am J Reprod Immunol 1992; 28: 153-6.
23. MATERNAL AND NEONATAL HAEMOSTASIS WORKING PARTY OF THE HAEMOSTASIS AND THROMBOSIS TASK: Guidelines on the prevention, investigation and management of thrombosis associated with pregnancy. J Clin Pathol 1993; 46: 489-96.
24. MELISSARI E, PARKER CJ, WILSON NV, MONTE G, KANTHOU C, PEMBERTON KD, NICOLAIDES KH, BARRETT JJ, KAKKAR VV: Use of low molecular weight heparin in pregnancy. Thromb Haemost 1992; 68: 652-6.
25. DAHLMAN TC: Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerpenum in 184 women undergoing thromboprophylaxis with heparin. Am J Obstet Gynecol 1993; 168: 1265-70.